Technologies
Our current advanced technology platforms are:-
Array based highly multiplexed real-time PCR
Provides the sensitivity of conventional real-time PCR, with the multiplexing capabilities of DNA arrays.
Array based sequencing-by-synthesis
Transforms conventional biochips into ultra-high throughput DNA sequencers, without secondary reaction steps i.e. the use of Sulfurylase and Luciferase or labelled nucleotide analogues.
Single-molecule sequencing
A process based upon the direct observation of immobilised polymerase systems. Proprietary IP, Mobious has exclusive has exclusive access to this patented technology.
Accelaffin™ hybridisation system
Mobious’ first commercially available product. Allows hybridisation within Genomic and Proteomic arrays in less than 10 minutes i.e. compared with a 12 to 48 hour requirement by competing expression targeted hybridisation systems.
Our current advanced technology platforms are:-
Array based highly multiplexed real-time PCR
Provides the sensitivity of conventional real-time PCR, with the multiplexing capabilities of DNA arrays.
Array based sequencing-by-synthesis
Transforms conventional biochips into ultra-high throughput DNA sequencers, without secondary reaction steps i.e. the use of Sulfurylase and Luciferase or labelled nucleotide analogues.
Single-molecule sequencing
A process based upon the direct observation of immobilised polymerase systems. Proprietary IP, Mobious has exclusive has exclusive access to this patented technology.
Accelaffin™ hybridisation system
Mobious’ first commercially available product. Allows hybridisation within Genomic and Proteomic arrays in less than 10 minutes i.e. compared with a 12 to 48 hour requirement by competing expression targeted hybridisation systems.